{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:49Z","timestamp":1781636089902,"version":"3.54.5"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) morbidity and mortality are increasing globally, including among patients living with human immunodeficiency virus (HIV). We aimed to determine the risk of all-cause mortality and morbidity in patients with CVD, comparing those with and without HIV infection, and whether mortality differed by HIV status during hospitalization for Major Adverse Cardiovascular Events (MACE) components (stroke, acute myocardial infarction (AMI), and heart failure) in northern Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study at two hospitals in northern Uganda, comparing outcomes in CVD patients with and without HIV hospitalized from January 2015 to June 2023. We utilized a logistic regression model for crude, adjusted, and stratified analyses of MACE components and mortality by HIV status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 2,127 CVD patient records analyzed, 292 (13.7%) had HIV. During hospitalization, 26.0% of patients living with HIV (PLWH) died compared with 15.8% of those without HIV. Similarly, among patients who experienced MACE, mortality was higher in PLWH than in those without HIV, including heart failure (38.1% vs. 22.9%), AMI (60.0% vs. 36.5%), and strokes (41.8% vs. 27.8%). In multivariable analyses, patients with cardiovascular disease living with HIV had higher odds of all-cause mortality compared with patients without HIV (aOR: 2.30, 95% CI: [1.32, 3.98],\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u20090.003). Among individual MACE components, the odds of mortality were higher among those living with HIV, including heart failure (aOR: 3.06, CI: [1.56, 6.32],\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u20090.001), AMI (aOR: 9.07, CI: [4.55, 18.77],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and stroke, (aOR: 2.5, CI: [1.15, 5.42],\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u20090.02). We assessed whether HIV modifies the relationship between MACE and odds of mortality, interaction terms (example, HIV*Stroke) showed no statistical evidence of effect modification, with HIV-interaction term\n                      <jats:italic>p<\/jats:italic>\n                      -values: heart failure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.465), stroke (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.613), and AMI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.615).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>All-cause mortality risk was higher among CVD patients living with HIV compared to those without. Although patients living with HIV who experienced MACE had higher in-hospital mortality, there was no statistical evidence of effect modification by HIV status. Further research is needed to understand the underlying pathophysiological mechanisms and mortality risks among patients hospitalized with MACE, including both medium- and long-term post hospitalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12895-6","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:15:34Z","timestamp":1771082134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Major adverse cardiovascular events, morbidity, and mortality, among people living with and without HIV in two northern Uganda hospitals"],"prefix":"10.1186","volume":"26","author":[{"given":"Mark","family":"Okwir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculate","family":"Akullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pancras","family":"Odongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Omech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kiweewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Bohjanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"12895_CR1","unstructured":"WHO. 2025. HIV data and statistics. [cited 4 Dec 2025]. Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics."},{"key":"12895_CR2","unstructured":"UNAIDS. 2025. Global HIV & AIDS statistics \u2014 Fact sheet | UNAIDS. [cited 4 Dec 2025]. Available: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"12895_CR3","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.5830\/CVJA-2015-036","volume":"26","author":"G Mensah","year":"2015","unstructured":"Mensah G, Roth G, Sampson U, Moran A, Feigin V, Forouzanfar M, et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990\u20132013: a systematic analysis of data from the global burden of disease study 2013: cardiovascular topic. Cardiovasc J Afr. 2015;26:S6\u201310. https:\/\/doi.org\/10.5830\/CVJA-2015-036.","journal-title":"Cardiovasc J Afr"},{"key":"12895_CR4","unstructured":"WHO. 2024. HIV data and statistics. [cited 21 Sept 2024]. Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics."},{"key":"12895_CR5","unstructured":"WHO 2024\u00a0N. Non communicable diseases. [cited 1 Oct 2024]. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases."},{"key":"12895_CR6","doi-asserted-by":"publisher","unstructured":"Future challenges for clinical. Care of an ageing population infected with HIV: a modelling study | Elsevier enhanced Reader. [cited 12 Apr 2023]. https:\/\/doi.org\/10.1016\/S1473-30991500056-0.","DOI":"10.1016\/S1473-30991500056-0"},{"key":"12895_CR7","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","volume":"118","author":"JS Currier","year":"2008","unstructured":"Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, et al. Epidemiological evidence for cardiovascular disease in HIV-Infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118:e29\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.189624.","journal-title":"Circulation"},{"key":"12895_CR8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV. Circulation. 2018;138:1100\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033369.","journal-title":"Circulation"},{"key":"12895_CR9","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol. 2022;80:2361\u201371. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.005.","journal-title":"J Am Coll Cardiol"},{"key":"12895_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","volume":"33","author":"JS Currier","year":"2003","unstructured":"Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, et al. Coronary heart disease in HIV-Infected individuals. JAIDS J Acquir Immune Defic Syndr. 2003;33:506.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"12895_CR11","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","volume":"92","author":"VA Triant","year":"2007","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506\u201312. https:\/\/doi.org\/10.1210\/jc.2006-2190.","journal-title":"J Clin Endocrinol Metab"},{"key":"12895_CR12","doi-asserted-by":"publisher","first-page":"e0176686","DOI":"10.1371\/journal.pone.0176686","volume":"12","author":"J Gutierrez","year":"2017","unstructured":"Gutierrez J, Albuquerque ALA, Falzon L. HIV infection as vascular risk: A systematic review of the literature and meta-analysis. PLoS ONE. 2017;12:e0176686. https:\/\/doi.org\/10.1371\/journal.pone.0176686.","journal-title":"PLoS ONE"},{"key":"12895_CR13","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1089\/aid.2012.0334","volume":"29","author":"MJ Vinikoor","year":"2013","unstructured":"Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY, Eron JJ. Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the southeastern united States. AIDS Res Hum Retroviruses. 2013;29:1068\u201374. https:\/\/doi.org\/10.1089\/aid.2012.0334.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"12895_CR14","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.02.016","volume":"27","author":"A Abdallah","year":"2018","unstructured":"Abdallah A, Chang JL, O\u2019Carroll CB, Musubire A, Chow FC, Wilson AL, et al. Stroke in HIV-infected individuals in sub-Saharan Africa (SSA): A systematic review. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2018;27:1828\u201336. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.02.016.","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"12895_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1212\/WNL.0000000000002278","volume":"86","author":"LA Benjamin","year":"2016","unstructured":"Benjamin LA, Corbett EL, Connor MD, Mzinganjira H, Kampondeni S, Choko A, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: A case-control study. Neurology. 2016;86:324\u201333. https:\/\/doi.org\/10.1212\/WNL.0000000000002278.","journal-title":"Neurology"},{"key":"12895_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21:241. https:\/\/doi.org\/10.1186\/s12874-021-01440-5.","journal-title":"BMC Med Res Methodol"},{"key":"12895_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jchf.2019.04.025","volume":"7","author":"RM Alvi","year":"2019","unstructured":"Alvi RM, Neilan AM, Tariq N, Hassan MO, Awadalla M, Zhang L, et al. The risk of sudden cardiac death among heart failure patients with HIV. JACC Heart Fail. 2019;7:759\u201367. https:\/\/doi.org\/10.1016\/j.jchf.2019.04.025.","journal-title":"JACC Heart Fail"},{"key":"12895_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/hiv.12687","volume":"20","author":"R Bijker","year":"2019","unstructured":"Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, et al. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV observational database (TAHOD). HIV Med. 2019;20:183\u201391. https:\/\/doi.org\/10.1111\/hiv.12687.","journal-title":"HIV Med"},{"key":"12895_CR19","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","volume":"59","author":"ZH Tseng","year":"2012","unstructured":"Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, et al. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012;59:1891\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.024.","journal-title":"J Am Coll Cardiol"},{"key":"12895_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","volume":"43","author":"FJJ Palella","year":"2006","unstructured":"Palella FJJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. JAIDS J Acquir Immune Defic Syndr. 2006;43:27. https:\/\/doi.org\/10.1097\/01.qai.0000233310.90484.16.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"12895_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","volume":"13","author":"F Islam","year":"2012","unstructured":"Islam F, Wu J, Jansson J, Wilson D. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13:453\u201368. https:\/\/doi.org\/10.1111\/j.1468-1293.2012.00996.x.","journal-title":"HIV Med"},{"key":"12895_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/COH.0000000000000755","volume":"17","author":"S Dirajlal-Fargo","year":"2022","unstructured":"Dirajlal-Fargo S, Funderburg N. HIV and cardiovascular disease: the role of inflammation. Curr Opin HIV AIDS. 2022;17:286. https:\/\/doi.org\/10.1097\/COH.0000000000000755.","journal-title":"Curr Opin HIV AIDS"},{"key":"12895_CR23","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1161\/CIRCRESAHA.124.323891","volume":"134","author":"LM Obare","year":"2024","unstructured":"Obare LM, Temu T, Mallal SA, Wanjalla CN. Inflammation in HIV and its impact on atherosclerotic cardiovascular disease. Circ Res. 2024;134:1515\u201345. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323891.","journal-title":"Circ Res"},{"key":"12895_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QAD.0000000000002794","volume":"35","author":"K Falasca","year":"2021","unstructured":"Falasca K, Lanuti P, Ucciferri C, Pieragostino D, Cufaro MC, Bologna G, et al. Circulating extracellular vesicles as new inflammation marker in HIV infection. AIDS. 2021;35:595. https:\/\/doi.org\/10.1097\/QAD.0000000000002794.","journal-title":"AIDS"},{"key":"12895_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijcard.2018.03.137","volume":"265","author":"OM Demir","year":"2018","unstructured":"Demir OM, Candilio L, Fuster D, Muga R, Barbaro G, Colombo A, et al. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol. 2018;265:195\u2013203. https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.137.","journal-title":"Int J Cardiol"},{"key":"12895_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cjca.2018.12.024","volume":"35","author":"PY Hsue","year":"2019","unstructured":"Hsue PY. Mechanisms of cardiovascular disease in the setting of HIV infection. Can J Cardiol. 2019;35:238\u201348. https:\/\/doi.org\/10.1016\/j.cjca.2018.12.024.","journal-title":"Can J Cardiol"},{"key":"12895_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/cid\/cir275","volume":"53","author":"SA Bozzette","year":"2011","unstructured":"Bozzette SA. HIV and cardiovascular disease. Clin Infect Dis. 2011;53:92\u20133. https:\/\/doi.org\/10.1093\/cid\/cir275.","journal-title":"Clin Infect Dis"},{"key":"12895_CR28","doi-asserted-by":"publisher","first-page":"e0282001","DOI":"10.1371\/journal.pone.0282001","volume":"18","author":"DM Byonanebye","year":"2023","unstructured":"Byonanebye DM, Polizzotto MN, Parkes-Ratanshi R, Musaazi J, Petoumenos K, Castelnuovo B. Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda. PLoS ONE. 2023;18:e0282001. https:\/\/doi.org\/10.1371\/journal.pone.0282001.","journal-title":"PLoS ONE"},{"key":"12895_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jash.2017.06.004","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens JASH. 2017;11:530\u201340. https:\/\/doi.org\/10.1016\/j.jash.2017.06.004.","journal-title":"J Am Soc Hypertens JASH"},{"key":"12895_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12879-023-08679-x","volume":"23","author":"KD Tegegne","year":"2023","unstructured":"Tegegne KD, Adela GA, Kassie GA, Mengstie MA, Seid MA, Zemene MA, et al. Prevalence and factors associated with hypertension among peoples living with HIV in East Africa, a systematic review and meta-analysis. BMC Infect Dis. 2023;23:724. https:\/\/doi.org\/10.1186\/s12879-023-08679-x.","journal-title":"BMC Infect Dis"},{"key":"12895_CR31","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk Factors, 1990\u20132019. J Am Coll Cardiol. 2020;76:2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"key":"12895_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11908-006-0037-1","volume":"8","author":"C Hadigan","year":"2006","unstructured":"Hadigan C. Diabetes, insulin resistance, and HIV. Curr Infect Dis Rep. 2006;8:69\u201375. https:\/\/doi.org\/10.1007\/s11908-006-0037-1.","journal-title":"Curr Infect Dis Rep"},{"key":"12895_CR33","doi-asserted-by":"publisher","first-page":"e013744","DOI":"10.1161\/JAHA.119.013744","volume":"9","author":"RS Rosenson","year":"2019","unstructured":"Rosenson RS, Hubbard D, Monda KL, Reading SR, Chen L, Dluzniewski PJ, et al. Excess risk for atherosclerotic cardiovascular outcomes among US adults with HIV in the current era. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2019;9:e013744. https:\/\/doi.org\/10.1161\/JAHA.119.013744.","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"12895_CR34","doi-asserted-by":"publisher","first-page":"e027670","DOI":"10.1161\/JAHA.122.027670","volume":"12","author":"JJ Noubiap","year":"2023","unstructured":"Noubiap JJ, Millenaar D, Ojji D, Wafford QE, Ukena C, B\u00f6hm M, et al. Fifty years of global cardiovascular research in africa: A scientometric Analysis, 1971 to 2021. J Am Heart Assoc. 2023;12:e027670. https:\/\/doi.org\/10.1161\/JAHA.122.027670.","journal-title":"J Am Heart Assoc"},{"key":"12895_CR35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","volume":"2","author":"MS Freiberg","year":"2017","unstructured":"Freiberg MS, Chang C-CH, Skanderson M, Patterson OV, DuVall SL, Brandt CA, et al. Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans aging cohort study. JAMA Cardiol. 2017;2:536\u201346. https:\/\/doi.org\/10.1001\/jamacardio.2017.0264.","journal-title":"JAMA Cardiol"},{"key":"12895_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614\u201322. https:\/\/doi.org\/10.1001\/jamainternmed.2013.3728.","journal-title":"JAMA Intern Med"},{"key":"12895_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","volume":"68","author":"A-L Paisible","year":"2015","unstructured":"Paisible A-L, Chang C-CH, So-Armah KA, Butt AA, Leaf DA, Budoff M, et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr 1999. 2015;68:209\u201316. https:\/\/doi.org\/10.1097\/QAI.0000000000000419.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"12895_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/QAD.0000000000001799","volume":"32","author":"FC Chow","year":"2018","unstructured":"Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the AIDS clinical trials group longitudinal linked randomized trials cohort. AIDS Lond Engl. 2018;32:1125\u201335. https:\/\/doi.org\/10.1097\/QAD.0000000000001799.","journal-title":"AIDS Lond Engl"},{"key":"12895_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2459\/JCM.0b013e328365ca31","volume":"16","author":"F D\u2019Ascenzo","year":"2015","unstructured":"D\u2019Ascenzo F, Quadri G, Cerrato E, Calcagno A, Omed\u00e8 P, Grosso Marra W, et al. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. J Cardiovasc Med. 2015;16:839. https:\/\/doi.org\/10.2459\/JCM.0b013e328365ca31.","journal-title":"J Cardiovasc Med"},{"key":"12895_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5334\/gh.815","volume":"16","author":"NQ Qureshi","year":"2021","unstructured":"Qureshi NQ, Mufarrih SH, Bloomfield GS, Tariq W, Almas A, Mokdad AH, et al. Disparities in cardiovascular research output and disease outcomes among High-, Middle- and Low-Income Countries - An analysis of global cardiovascular publications over the last decade (2008\u20132017). Glob Heart. 2021;16:4. https:\/\/doi.org\/10.5334\/gh.815.","journal-title":"Glob Heart"},{"key":"12895_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/CLEP.S129728","volume":"9","author":"P Corraini","year":"2017","unstructured":"Corraini P, Olsen M, Pedersen L, Dekkers OM, Vandenbroucke JP. Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators. Clin Epidemiol. 2017;9:331\u20138. https:\/\/doi.org\/10.2147\/CLEP.S129728.","journal-title":"Clin Epidemiol"},{"key":"12895_CR42","unstructured":"Lira H. 2022. Available: https:\/\/budget.finance.go.ug\/sites\/default\/files\/Sector%20Spending%20Agency%20Budgets%20and%20Performance\/Lira%20Hospital_1.pdf."},{"key":"12895_CR43","doi-asserted-by":"publisher","first-page":"1684070","DOI":"10.1080\/16549716.2019.1684070","volume":"12","author":"A DeWyer","year":"2019","unstructured":"DeWyer A, Scheel A, Otim IO, Longenecker CT, Okello E, Ssinabulya I, et al. Improving the accuracy of heart failure diagnosis in low-resource settings through task sharing and decentralization. Glob Health Action. 2019;12:1684070. https:\/\/doi.org\/10.1080\/16549716.2019.1684070.","journal-title":"Glob Health Action"},{"key":"12895_CR44","unstructured":"Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda. (2020). Available: https:\/\/elearning.idi.co.ug\/wp-content\/uploads\/2022\/05\/Consolidated-Guidelines-for-the-Prevention-and-Treatment-of-HIV-and-AIDS-in-Uganda-2020.pdf."},{"key":"12895_CR45","unstructured":"World Health Organization. 2021. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. [cited 23 Dec 2023]. Available: https:\/\/www.who.int\/publications-detail-redirect\/9789240031593."},{"key":"12895_CR46","doi-asserted-by":"publisher","first-page":"e012241","DOI":"10.1161\/JAHA.119.012241","volume":"8","author":"A Alonso","year":"2019","unstructured":"Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. 2019;8:e012241. https:\/\/doi.org\/10.1161\/JAHA.119.012241.","journal-title":"J Am Heart Assoc"},{"key":"12895_CR47","doi-asserted-by":"publisher","first-page":"e0230730","DOI":"10.1371\/journal.pone.0230730","volume":"15","author":"G Touloumi","year":"2020","unstructured":"Touloumi G, Kalpourtzi N, Papastamopoulos V, Paparizos V, Adamis G, Antoniadou A, et al. Cardiovascular risk factors in HIV infected individuals: comparison with general adult control population in Greece. PLoS ONE. 2020;15:e0230730. https:\/\/doi.org\/10.1371\/journal.pone.0230730.","journal-title":"PLoS ONE"},{"key":"12895_CR48","doi-asserted-by":"publisher","first-page":"e000055","DOI":"10.1136\/bmjgh-2016-000055","volume":"1","author":"R Kalyesubula","year":"2016","unstructured":"Kalyesubula R, Kayongo A, Semitala FC, Muhanguzi A, Katantazi N, Ayers D, et al. Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, uganda: a retrospective study. BMJ Glob Health. 2016;1:e000055. https:\/\/doi.org\/10.1136\/bmjgh-2016-000055.","journal-title":"BMJ Glob Health"},{"key":"12895_CR49","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/hiv.13080","volume":"22","author":"G Massah","year":"2021","unstructured":"Massah G, Zhang W, Birungi J, Nanfuka M, Zhu J, Okoboi S, et al. Gender disparities operate in opposite directions for hospitalizations and mortality among individuals receiving long-term ART in rural Uganda. HIV Med. 2021;22:512\u20138. https:\/\/doi.org\/10.1111\/hiv.13080.","journal-title":"HIV Med"},{"key":"12895_CR50","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","volume":"127","author":"L Lorgis","year":"2013","unstructured":"Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, et al. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation. 2013;127:1767\u201374. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001874.","journal-title":"Circulation"},{"key":"12895_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/EDE.0000000000000041","volume":"25","author":"ES Brouwer","year":"2014","unstructured":"Brouwer ES, Napravnik S, Eron JJ, Stalzer B, Floris-Moore M, Simpson RJ, et al. Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients. Epidemiol Camb Mass. 2014;25:406\u201317. https:\/\/doi.org\/10.1097\/EDE.0000000000000041.","journal-title":"Epidemiol Camb Mass"},{"key":"12895_CR52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","volume":"75","author":"DR Drozd","year":"2017","unstructured":"Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, et al. Increased risk of myocardial infarction in HIV-Infected individuals in North America compared with the general population. J Acquir Immune Defic Syndr 1999. 2017;75:568\u201376. https:\/\/doi.org\/10.1097\/QAI.0000000000001450.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"12895_CR53","doi-asserted-by":"publisher","first-page":"e025874","DOI":"10.1136\/bmjopen-2018-025874","volume":"9","author":"O Eyawo","year":"2019","unstructured":"Eyawo O, Brockman G, Goldsmith CH, Hull MW, Lear SA, Bennett M, et al. Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis. BMJ Open. 2019;9:e025874. https:\/\/doi.org\/10.1136\/bmjopen-2018-025874.","journal-title":"BMJ Open"},{"key":"12895_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12916-019-1385-7","volume":"17","author":"MJ Feinstein","year":"2019","unstructured":"Feinstein MJ, Nance RM, Delaney JAC, Heckbert SR, Budoff MJ, Drozd DR, et al. Mortality following myocardial infarction among HIV-infected persons: the center for AIDS research network of integrated clinical systems (CNICS). BMC Med. 2019;17:149. https:\/\/doi.org\/10.1186\/s12916-019-1385-7.","journal-title":"BMC Med"},{"key":"12895_CR55","doi-asserted-by":"publisher","unstructured":"Alsheikh MM, Alsheikh AM. Risk of myocardial infarction in HIV patients: a systematic review. Cureus. 14:e31825. https:\/\/doi.org\/10.7759\/cureus.31825.","DOI":"10.7759\/cureus.31825"},{"key":"12895_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neurol.2018.09.020","volume":"175","author":"YN Mapoure","year":"2019","unstructured":"Mapoure YN, Mondomobe CAA, Nkouonlack C, Ayeah CM, Luma HN, Njamnshi AK. HIV infection does not influence stroke outcomes in HIV-infected patients: A prospective study. Rev Neurol (Paris). 2019;175:313\u20138. https:\/\/doi.org\/10.1016\/j.neurol.2018.09.020.","journal-title":"Rev Neurol (Paris)"},{"key":"12895_CR57","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1056\/NEJMoa022048","volume":"348","author":"SA Bozzette","year":"2003","unstructured":"Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348:702\u201310. https:\/\/doi.org\/10.1056\/NEJMoa022048.","journal-title":"N Engl J Med"},{"key":"12895_CR58","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/febs.14657","volume":"286","author":"C Marincowitz","year":"2019","unstructured":"Marincowitz C, Genis A, Goswami N, De Boever P, Nawrot TS, Strijdom H. Vascular endothelial dysfunction in the wake of HIV and ART. FEBS J. 2019;286:1256\u201370. https:\/\/doi.org\/10.1111\/febs.14657.","journal-title":"FEBS J"},{"key":"12895_CR59","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/infdis\/jiab420","volume":"225","author":"TE Gooden","year":"2021","unstructured":"Gooden TE, Gardner M, Wang J, Jolly K, Lane DA, Benjamin LA, et al. Incidence of cardiometabolic diseases in people with and without human immunodeficiency virus in the united kingdom: A Population-Based matched cohort study. J Infect Dis. 2021;225:1348\u201356. https:\/\/doi.org\/10.1093\/infdis\/jiab420.","journal-title":"J Infect Dis"},{"key":"12895_CR60","doi-asserted-by":"publisher","unstructured":"Sr RBD, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart. 2013;8:11\u201323. https:\/\/doi.org\/10.1016\/j.gheart.2013.01.001.","DOI":"10.1016\/j.gheart.2013.01.001"},{"key":"12895_CR61","doi-asserted-by":"publisher","unstructured":"Zhu S, Wang W, He J, Duan W, Ma X, Guan H, et al. Higher cardiovascular disease risks in people living with HIV: a systematic review and meta-analysis. J Glob Health. 14:04078. https:\/\/doi.org\/10.7189\/jogh.14.04078.","DOI":"10.7189\/jogh.14.04078"},{"key":"12895_CR62","doi-asserted-by":"publisher","first-page":"102654","DOI":"10.1016\/j.jiph.2025.102654","volume":"18","author":"M Du","year":"2025","unstructured":"Du M, Zhang S, Liu M, Liu J. Cardiovascular disease and its risk factors among people living with HIV: A systematic review and meta-analysis. J Infect Public Health. 2025;18:102654. https:\/\/doi.org\/10.1016\/j.jiph.2025.102654.","journal-title":"J Infect Public Health"},{"key":"12895_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.athplu.2024.01.003","volume":"55","author":"H Mokoena","year":"2024","unstructured":"Mokoena H, Mabhida SE, Choshi J, Dludla PV, Nkambule BB, Mchiza ZJ, et al. Endothelial dysfunction and cardiovascular diseases in people living with HIV on specific highly active antiretroviral therapy regimen: A systematic review of clinical studies. Atheroscler Plus. 2024;55:47\u201354. https:\/\/doi.org\/10.1016\/j.athplu.2024.01.003.","journal-title":"Atheroscler Plus"},{"key":"12895_CR64","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.cpcardiol.2020.100615","volume":"46","author":"BF Ebner","year":"2021","unstructured":"Ebner BF, Chueng T, Martinez CA. Epigenetics, HIV, and cardiovascular disease risk. Curr Probl Cardiol. 2021;46:100615. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100615.","journal-title":"Curr Probl Cardiol"},{"key":"12895_CR65","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/CIRCRESAHA.124.323979","volume":"134","author":"P Prakash","year":"2024","unstructured":"Prakash P, Swami Vetha BS, Chakraborty R, Wenegieme T-Y, Masenga SK, Muthian G, et al. HIV-Associated hypertension: Risks, Mechanisms, and knowledge gaps. Circ Res. 2024;134:e150\u201375. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323979.","journal-title":"Circ Res"},{"key":"12895_CR66","unstructured":"Ucciferri C, Vecchiet J, Falasca K. Hypertension in HIV: management and treatment. Aids Rev. 2017 [cited 5 Dec 2025]. Available: https:\/\/aidsreviews.com\/en\/2017\/hypertension-in-hiv-management-and-treatment\/."},{"key":"12895_CR67","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.3390\/ijms262110285","volume":"26","author":"H Mokoena","year":"2025","unstructured":"Mokoena H, Choshi J, Hanser S, Mabhida SE, Steel HC, Mokgalaboni K, et al. Sustained activation of myeloperoxidase is associated with oxidative stress and inflammation in people living with the human immunodeficiency virus at risk of cardiovascular disease. Int J Mol Sci. 2025;26:10285. https:\/\/doi.org\/10.3390\/ijms262110285.","journal-title":"Int J Mol Sci"},{"key":"12895_CR68","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/COH.0000000000000406","volume":"12","author":"RA van Zoest","year":"2017","unstructured":"van Zoest RA, van den Born B-JH, Reiss P. Hypertension in people living with HIV. Curr Opin HIV AIDS. 2017;12:513. https:\/\/doi.org\/10.1097\/COH.0000000000000406.","journal-title":"Curr Opin HIV AIDS"},{"key":"12895_CR69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jhh.2015.97","volume":"30","author":"CU Nduka","year":"2016","unstructured":"Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens. 2016;30:355\u201362. https:\/\/doi.org\/10.1038\/jhh.2015.97.","journal-title":"J Hum Hypertens"},{"key":"12895_CR70","doi-asserted-by":"publisher","unstructured":"Ambrosioni J, Levi LI, Alagaratnam J, Sempere A, Mastrangelo A, Paioni P, et al. Major revision version 13.0 of the European AIDS clinical society guidelines 2025. HIV Med n\/a https:\/\/doi.org\/10.1111\/hiv.70120.","DOI":"10.1111\/hiv.70120"},{"key":"12895_CR71","doi-asserted-by":"crossref","unstructured":"Yu J, Liu X, Zhu Z, Yang Z, He J, Zhang L, et al. Prediction models for cardiovascular disease risk among people living with HIV: A SYSTEMatic review and meta-analysis. Front Cardiovasc Med. 2023;10. Available: https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1138234.","DOI":"10.3389\/fcvm.2023.1138234"},{"key":"12895_CR72","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/cid\/ciw615","volume":"63","author":"AM Thompson-Paul","year":"2016","unstructured":"Thompson-Paul AM, Lichtenstein KA, Armon C, Palella FJ, Skarbinski J, Chmiel JS, et al. Cardiovascular disease risk prediction in the HIV outpatient study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;63:1508\u201316. https:\/\/doi.org\/10.1093\/cid\/ciw615.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"12895_CR73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamacardio.2022.4873","volume":"8","author":"C Soares","year":"2023","unstructured":"Soares C, Kwok M, Boucher K-A, Haji M, Echouffo-Tcheugui JB, Longenecker CT, et al. Performance of cardiovascular risk prediction models among people living with HIV: A systematic review and Meta-analysis. JAMA Cardiol. 2023;8:139\u201349. https:\/\/doi.org\/10.1001\/jamacardio.2022.4873.","journal-title":"JAMA Cardiol"},{"key":"12895_CR74","unstructured":"WHO. 2024. Determinants of health. [cited 27 Apr 2025]. Available: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/determinants-of-health."},{"key":"12895_CR75","doi-asserted-by":"publisher","first-page":"e029228","DOI":"10.1161\/JAHA.123.029228","volume":"13","author":"VA Triant","year":"2024","unstructured":"Triant VA, Lyass A, Hurley LB, Borowsky LH, Ehrbar RQ, He W, et al. Cardiovascular risk Estimation is suboptimal in people with HIV. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2024;13:e029228. https:\/\/doi.org\/10.1161\/JAHA.123.029228.","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"12895_CR76","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/08971900211000700","volume":"35","author":"AE \u00d6zdener-Poyraz","year":"2022","unstructured":"\u00d6zdener-Poyraz AE, Vaidean G. Preventive cardiovascular care in patients with HIV infection in an outpatient clinic. J Pharm Pract. 2022;35:612\u20136. https:\/\/doi.org\/10.1177\/08971900211000700.","journal-title":"J Pharm Pract"},{"key":"12895_CR77","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa030218","volume":"349","author":"The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group","year":"2003","unstructured":"The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993\u20132003. https:\/\/doi.org\/10.1056\/NEJMoa030218.","journal-title":"N Engl J Med"},{"key":"12895_CR78","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/cid\/cir269","volume":"53","author":"RJ Bedimo","year":"2011","unstructured":"Bedimo RJ, Westfall AO, Drechsler H, Vidiella G, Tebas P. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clin Infect Dis. 2011;53:84\u201391. https:\/\/doi.org\/10.1093\/cid\/cir269.","journal-title":"Clin Infect Dis"},{"key":"12895_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/135965350801300215","volume":"13","author":"AN Phillips","year":"2008","unstructured":"Phillips AN, Carr A, Neuhaus J, Visnegarwala F, Prineas R, Burman WJ, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther. 2008;13:177\u201388. https:\/\/doi.org\/10.1177\/135965350801300215.","journal-title":"Antivir Ther"},{"key":"12895_CR80","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jchf.2019.12.007","volume":"8","author":"S Erqou","year":"2020","unstructured":"Erqou S, Jiang L, Choudhary G, Lally M, Bloomfield GS, Zullo AR, et al. Heart failure outcomes and associated factors among veterans with human immunodeficiency virus infection. JACC Heart Fail. 2020;8:501\u201311. https:\/\/doi.org\/10.1016\/j.jchf.2019.12.007.","journal-title":"JACC Heart Fail"},{"key":"12895_CR81","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/S2352-3018(21)00329-5","volume":"9","author":"N Ford","year":"2022","unstructured":"Ford N, Patten G, Rangaraj A, Davies M-A, Meintjes G, Ellman T. Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. Lancet HIV. 2022;9:e150\u20139. https:\/\/doi.org\/10.1016\/S2352-3018(21)00329-5.","journal-title":"Lancet HIV"},{"key":"12895_CR82","doi-asserted-by":"publisher","first-page":"e2411159","DOI":"10.1001\/jamanetworkopen.2024.11159","volume":"7","author":"M Haji","year":"2024","unstructured":"Haji M, Capilupi M, Kwok M, Ibrahim N, Bloomfield GS, Longenecker CT, et al. Clinical outcomes after acute coronary syndromes or revascularization among people living with HIV: A systematic review and Meta-Analysis. JAMA Netw Open. 2024;7:e2411159. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.11159.","journal-title":"JAMA Netw Open"},{"key":"12895_CR83","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618\u201351. https:\/\/doi.org\/10.1161\/CIR.0000000000000617.","journal-title":"Circulation"},{"key":"12895_CR84","unstructured":"World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. Geneva: World Health Organization. 2017. Available: https:\/\/iris.who.int\/handle\/10665\/255884."},{"key":"12895_CR85","unstructured":"WHO 2016 Regional office for Africa. Uganda launches HIV\/AIDS test and treat guidelines at World AIDS Day commemoration | WHO | Regional Office for Africa. 29 Aug 2025 [cited 31 Aug 2025]. Available: https:\/\/www.afro.who.int\/news\/uganda-launches-hivaids-test-and-treat-guidelines-world-aids-day-commemoration."},{"key":"12895_CR86","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2304146","volume":"389","author":"SK Grinspoon","year":"2023","unstructured":"Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, et al. Pitavastatin to prevent cardiovascular disease in HIV infection. N Engl J Med. 2023;389:687\u201399. https:\/\/doi.org\/10.1056\/NEJMoa2304146.","journal-title":"N Engl J Med"},{"key":"12895_CR87","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jacbts.2022.06.002","volume":"7","author":"E Marcantoni","year":"2022","unstructured":"Marcantoni E, Garshick MS, Schwartz T, Ratnapala N, Cambria M, Dann R, et al. Antiplatelet effects of clopidogrel vs aspirin in virologically controlled HIV. JACC Basic Transl Sci. 2022;7:1086\u201397. https:\/\/doi.org\/10.1016\/j.jacbts.2022.06.002.","journal-title":"JACC Basic Transl Sci"},{"key":"12895_CR88","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC). Eur Heart J. 2020;41:407\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425.","journal-title":"Eur Heart J"},{"key":"12895_CR89","doi-asserted-by":"publisher","unstructured":"Gallis JA, Turner EL. Relative measures of association for binary outcomes: challenges and recommendations for the global health researcher. Ann Glob Health. 85:137. https:\/\/doi.org\/10.5334\/aogh.2581.","DOI":"10.5334\/aogh.2581"},{"key":"12895_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12874-018-0519-5","volume":"18","author":"W Chen","year":"2018","unstructured":"Chen W, Qian L, Shi J, Franklin M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med Res Methodol. 2018;18:63. https:\/\/doi.org\/10.1186\/s12874-018-0519-5.","journal-title":"BMC Med Res Methodol"},{"key":"12895_CR91","doi-asserted-by":"publisher","unstructured":"Sawada K, Hagiwara Y, Matsuyama Y. Choosing between modified Poisson and log-binomial regression: evidence for the superiority of modified Poisson regression under heterogeneous risk ratios. Am J Epidemiol. 2025;kwaf232. https:\/\/doi.org\/10.1093\/aje\/kwaf232.","DOI":"10.1093\/aje\/kwaf232"},{"key":"12895_CR92","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/archpediatrics.2009.31","volume":"163","author":"P Cummings","year":"2009","unstructured":"Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163:438\u201345. https:\/\/doi.org\/10.1001\/archpediatrics.2009.31.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"12895_CR93","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/biom.13197","volume":"76","author":"TJ VanderWeele","year":"2020","unstructured":"VanderWeele TJ. Optimal approximate conversions of odds ratios and hazard ratios to risk ratios. Biometrics. 2020;76:746\u201352. https:\/\/doi.org\/10.1111\/biom.13197.","journal-title":"Biometrics"},{"key":"12895_CR94","doi-asserted-by":"publisher","unstructured":"DATA: Morbidity and mortality in cardiac patients with adverse cardiovascular events and HIV exposure. figshare. 2025. https:\/\/doi.org\/10.6084\/m9.figshare.29926988.v1.","DOI":"10.6084\/m9.figshare.29926988.v1"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12895-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:16:57Z","timestamp":1781633817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12895-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12895"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12895-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Gulu University Research Ethics Committee (GUREC-2022-198), renewed in July 2023 and the Uganda National Council of Science and Technology (UNCST: HS2322ES) and renewed by the GUREC. The study met the international standards for human subject protection and adhered to the principles outlined in the Declaration of Helsinki. We obtained institutional permission and a waiver of consent from GUREC to use deidentified secondary data because we could not trace all the patients previously admitted to these facilities to obtain consent. We adhered to ethical principles for research involving human subjects throughout the entire study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"609"}}